Document 2336
 DOCN  M94A2336
 TI    1992 new AIDS case rate, by country and WHO-region.
 DT    9412
 AU    Bernard RP; AIDS FEEDBACK, Liaison UN & NG Organizations, Geneve/Suisse.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):327 (abstract no. PC0239). Unique
       Identifier : AIDSLINE ICA10/94370239
 AB    OBJECTIVE: To repeat/test last year's method[PO-CO4-2669] by calculating
       1992 new AIDS case rates (vs 1991 last year) for comparing the birank
       system for 3 consecutive calendar years. Hypothesis: for 1992 the birank
       structure is quite similar to those of 1991 & 1990. AIDS incidence for
       1992 will thus again point to the main world routes of AIDS appearance,
       hence HIV spread status around 1 decade earlier. World view. METHODS:
       Only official GOV reporting of AIDS is used. The new AIDS cases for 1992
       (diagnosis preferred over reporting) are given as crude AIDS case
       rates/10(5) mid-1992 population. Their 'high-low' dual ranking
       (global/regional) generates the 3rd such global overview with highest
       rates at the left top and the lowest rates at the right bottom. Order.
       RESULTS: Again, the 1992 AIDS case rates assume a descending staircase
       like arrangement across the 6 WHO-regions in this order: AFRO/AMRO
       (PAHO)/EURO/WPRO/EMRO/SEARO. Some progressing country exceptions will
       need poster discussion. One region will be developed in GEO-2 detail.
       DISCUSSION AND CONCLUSIONS: With a reporting grace period of 18 months
       beyond 1992, bias by reporting delay is decreased. With around 10
       african countries in lead [World & AFRO ranks quasi identical] last
       year's hypothesis is further strengthened regarding origin (central/east
       Africa) and early reception in the Caribbean. Prevention programs have
       to be intensified in current low incidence countries.
 DE    Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/PREVENTION &  CONTROL
       Africa/EPIDEMIOLOGY  Comparative Study  *Cross-Cultural Comparison
       Human  HIV Seroprevalence/*TRENDS  Risk Factors  World Health
       Organization  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).